In patients with chronic myelogenous leukemia, Jani-Sofia Almeida observed significant alterations on the expression of tumor recognition (NCRsandNKp80) and immune regulatory receptors (LAG-3, TIM-3, and CD137) by NKT-like cells [2]. This evidence concerns the gene HAVCR2 and chronic myelogenous leukemia, BCR-ABL1 positive.